申请人:University of Pittsburgh - Of the Commonwealth
System of Higher Education
公开号:EP3045167A1
公开(公告)日:2016-07-20
Compounds of formula I and their metabolites are potent mediators of an inflammatory response:
where a, b, c, d, e, f, V, W, X, Y, Ra, Ra', Rb, Rb', Rc, and Rc' are defined herein. In particular, the compounds of the invention are candidate therapeutics for treating inflammatory conditions.
式 I 的化合物及其代谢物是炎症反应的强效介质:
其中 a、b、c、d、e、f、V、W、X、Y、Ra、Ra'、Rb、Rb'、Rc 和 Rc' 在本文中定义。尤其是,本发明的化合物是治疗炎症的候选疗法。